HeartForce aims to enable early coronary artery disease screening.
The company’s mission is to enable preventive heart screening for all. CardioClin is intended to support healthcare professionals in screening for coronary artery disease risk; it is not a diagnostic device and does not replace clinical judgment or confirmatory testing.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
CardioClin is powered by an AI-driven proprietary Electro-Mechanical Cardiac Risk Score and is described as non-invasive and radiation-free, with results in 60 seconds.
Source: LinkedIn company description · Retrieved October 13, 2026
The solution is intended for symptomatic and asymptomatic individuals and is described as scalable across primary care, emergency medical services, pharmacies, sport clubs, military, and diagnostic centers.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.